(주)엔솔바이오사이언스

{
  "address": "대전 유성구",
  "ceo_name": "김해진",
  "certificate": [
    {
      "cert_number": "011534133101116",
      "changes": "",
      "disclosure_date": "2001-06-21",
      "first_cert_date": "2001-06-21",
      "no": "1",
      "type": "연구개발기업",
      "valid_period": "2001-06-21 ~ 2003-06-20"
    },
    {
      "cert_number": "031534221200177",
      "changes": "",
      "disclosure_date": "2003-06-21",
      "first_cert_date": "2001-06-21",
      "no": "2",
      "type": "연구개발기업",
      "valid_period": "2003-06-21 ~ 2005-06-20"
    },
    {
      "cert_number": "051534221300239",
      "changes": "",
      "disclosure_date": "2005-06-21",
      "first_cert_date": "2001-06-21",
      "no": "3",
      "type": "연구개발기업",
      "valid_period": "2005-06-21 ~ 2007-06-20"
    },
    {
      "cert_number": "20070102492",
      "changes": "",
      "disclosure_date": "2007-08-01",
      "first_cert_date": "2001-06-21",
      "no": "4",
      "type": "연구개발유형",
      "valid_period": "2007-06-21 ~ 2009-06-20"
    },
    {
      "cert_number": "20090105917",
      "changes": "",
      "disclosure_date": "2009-06-22",
      "first_cert_date": "2001-06-21",
      "no": "5",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2009-06-21 ~ 2011-06-20"
    },
    {
      "cert_number": "20110104495",
      "changes": "",
      "disclosure_date": "2011-07-15",
      "first_cert_date": "2001-06-21",
      "no": "6",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2011-06-21 ~ 2013-06-20"
    },
    {
      "cert_number": "20130105752",
      "changes": "",
      "disclosure_date": "2013-06-17",
      "first_cert_date": "2001-06-21",
      "no": "7",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2013-06-21 ~ 2015-06-20"
    },
    {
      "cert_number": "20150108131",
      "changes": "",
      "disclosure_date": "2015-08-05",
      "first_cert_date": "2001-06-21",
      "no": "8",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2015-06-21 ~ 2017-06-20"
    },
    {
      "cert_number": "20170300305",
      "changes": "",
      "disclosure_date": "2017-06-22",
      "first_cert_date": "2001-06-21",
      "no": "9",
      "type": "벤처투자유형",
      "valid_period": "2017-06-21 ~ 2019-06-20"
    },
    {
      "cert_number": "20190300450",
      "changes": "",
      "disclosure_date": "2019-05-30",
      "first_cert_date": "2001-06-21",
      "no": "10",
      "type": "벤처투자유형",
      "valid_period": "2019-06-21 ~ 2021-06-20"
    },
    {
      "cert_number": "20210721020039",
      "changes": "",
      "disclosure_date": "2021-07-21",
      "first_cert_date": "2001-06-21",
      "no": "11",
      "type": "연구개발유형",
      "valid_period": "2021-06-21 ~ 2024-06-20"
    },
    {
      "cert_number": "20240730020017",
      "changes": "",
      "disclosure_date": "2024-07-30",
      "first_cert_date": "2001-06-21",
      "no": "12",
      "type": "연구개발유형",
      "valid_period": "2024-06-21 ~ 2027-06-20"
    }
  ],
  "company_name": "(주)엔솔바이오사이언스",
  "corp_no": "160111-*******",
  "financials": {
    "2022": {
      "capital_stock": 4804905000,
      "cost_of_sales": 111736000,
      "current_assets": 8004104000,
      "current_liabilities": 16752086000,
      "gross_profit": 747779000,
      "net_income": -4963626000,
      "net_income_bs": -4914569000,
      "non_current_assets": 5122113000,
      "non_current_liabilities": 2182057000,
      "non_operating_expenses": 1688628000,
      "non_operating_income": 4864144000,
      "operating_profit": -8139142000,
      "revenue": 859515000,
      "sga_expenses": 8886921000,
      "total_assets": 13126217000,
      "total_equity": -5807926000,
      "total_liabilities": 18934143000
    },
    "2023": {
      "capital_stock": 5413907000,
      "cost_of_sales": 47229000,
      "current_assets": 4745769000,
      "current_liabilities": 12575310000,
      "gross_profit": 129316000,
      "net_income": -11292962000,
      "net_income_bs": -11302099000,
      "non_current_assets": 4648801000,
      "non_current_liabilities": 2271506000,
      "non_operating_expenses": 2440898000,
      "non_operating_income": 719130000,
      "operating_profit": -9571194000,
      "revenue": 176545000,
      "sga_expenses": 9700510000,
      "total_assets": 9394570000,
      "total_equity": -5452246000,
      "total_liabilities": 14846816000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [
    {
      "amount": "999,000,000",
      "changes": "999,000,000",
      "date": "2016-06-28"
    }
  ],
  "main_products": "퇴행성디스크 치료제,골관절염 치료제,동물용 골관절염 치료제 연구,개발용역/생물정보분석시스템 개발,컴퓨터시스템 설계자문,데이터베이스 구축,가공/컴퓨터",
  "phone": "042-939-****",
  "years": [
    2023,
    2022
  ]
}